Biotech entity

Arizona

government

Of the tracked stories, 1 of 2 also mention CDC, the most common co-covered peer. That works out to roughly 0.6 stories per week across a 25-day span. They are better corroborated than the beat average, carrying 8.5 original sources each against 3.4 for the same window.

Last mentioned: Mar 21, 2026

Entity pulse

Recent coverage · Arizona

2 stories
7.5 avg impact
0% positive
100% negative

Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.

  • 100% negative

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Arizona

Of the tracked stories, 1 of 2 also mention CDC, the most common co-covered peer. That works out to roughly 0.6 stories per week across a 25-day span. They are better corroborated than the beat average, carrying 8.5 original sources each against 3.4 for the same window. Their average consequence score of 7.5 runs above the beat's 6.1 for that window. fda-approval accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder. Arizona appears in 2 tracked Biotech stories published from February 25, 2026 through March 21, 2026.

Stories tracked
2
Per week
0.6
Sources per story
8.5

Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 328 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Arizona. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Pharma and Corporate Shifts

    Strides Pharma announces ibuprofen recall; Compass drops Zillow lawsuit to focus on operations.

  2. Global Contagion

    Asian and European markets sell off; Planet Labs reports widening Q4 losses.

  3. Legal and Macro Shock

    Arizona files criminal charges against Kalshi; Jerome Powell issues hawkish inflation warnings.

  4. Expected Response

    The Trump administration is expected to file its initial legal defense regarding executive agency authority.

  5. Public Announcement

    Arizona and other state attorneys general publicly detail the health risks associated with the vaccine rollback.

  6. Lawsuit Filed

    A coalition of states files a formal complaint against the Trump administration in federal court.

Stories mentioning Arizona 2

FDA Actions Negative

Arizona Files Criminal Charges Against Kalshi Amid Broad Market Sell-Off

Arizona has initiated criminal proceedings against prediction market Kalshi for alleged illegal betting, occurring simultaneously with a global market downturn triggered by Federal Reserve inflation warnings. In the pharmaceutical sector, Strides Pharma has issued a recall for children's ibuprofen, highlighting operational risks during a period of heightened regulatory and economic pressure.

15 sources
Pharma Negative

States Sue Trump Administration Over Childhood Vaccine Recommendation Rollback

A coalition of over a dozen states, led by Arizona, has filed a federal lawsuit against the Trump administration to block the rollback of childhood vaccine recommendations. The plaintiffs argue that the changes to CDC guidelines bypass scientific protocols and present an immediate threat to national public health safety.

2 sources

Arizona is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.